The Foundation

David spent 6 months short of 50 years in the oil industry. In 1992 David co-founded Greenergy which is now the UK’s largest downstream oil company by some distance.

The company was sold in May 2017 and the resulting proceeds were bequeathed to Seerave to fund its research and philanthropic activities.

Elisabeth has more than twenty years of experience working within Fine Arts and Museums in Sweden as a Project Manager, Programmer, Curator, and Museum Director.

Prior to her Fine Arts studies, she trained as a nurse. In 2016 she joined her father to build up the Seerave Foundation with the conviction to change the standard of care for cancer patients.

Manuel is a PhD-level tumor immunologist passionate about turning microbiome science into actionable therapies.

He has been involved in multiple startups, was co-founder and president of Innovation Forum Lausanne, and a former Fellow at the innovation foundry at Flagship Pioneering.

Laura is a PhD-level health scientist and has previously overseen a clinical FMT trial in depressed patients, supported by Seerave.

She is particularly passionate about translational approaches from science to society. Further, she has built a track record in human-centered innovation methods.

Carolyn has founded and led organizations dedicated to delivering new microbiome-based solutions in health and the environment.

She was a co-founder and executive director of OpenBiome, the first public stool bank, which brought fecal microbiota transplantation to more than 70,000 patients at 1300 hospitals and clinics in the U.S.

She also co-founded Ample Agriculture, which is working to reduce enteric methane emissions from livestock.

She is inspired by opportunities to help promising ideas realize their potential for improving health and welfare.

Andrew has a background in data science and bioinformatics, and has contributed to the development of live biotherapeutic products in the biotech sector as well as leading analyses of clinical trial data.

He is passionate about translating scientific breakthroughs into tangible innovations for humanity.

Dr. Laura Bolte is a dietitian and medical doctor with a PhD on diet–microbiome interactions in intestinal inflammation and cancer immunotherapy.

As a Clinical Scientist at UDEM, Bern, she works to integrate nutrition into clinical care and studies how diet, lifestyle and medications—including antibiotics and GLP-1 therapies—shape the microbiome and ICI responses, supporting Seerave in establishing the Global Oncobiome Atlas.

Shubhangi holds a background in scientific research, with experience at leading institutions including the Max Planck Institute, where her work contributed to peer-reviewed publications.

She has since built expertise in operations and administration, supporting founders and leadership teams across start-up environments in Germany.

Now in Switzerland at Seerave, she bridges the bench and the boardroom to keep the team focused on what matters.

Mark is a microbiologist and entrepreneur dedicated to harnessing microbes to improve human health and the environment.

Through his work enabling clinical research and patient access to novel microbial therapies Mark has seen first-hand the potential impact this work can have on patient lives.

Mark has served in executive and board positions across multiple biotechnology companies pioneering microbiome science, including as a founder at OpenBiome, Finch Therapeutics (Nasdaq: FNCH), and Ample Agriculture and as a founding board member at Freya Biosciences and Florey Biosciences. 

Ainara has 9 years of experience in the medical device industry as an electrical engineer, project manager and product & strategy analyst.

She has been working in the past years for different start-up companies and a non-for-profit foundation in Switzerland.

She is passionate about human centered translational approaches from science to the market and clinical practice.

Dr. Martin Blaser holds the Henry Rutgers Chair of the Human Microbiome at Rutgers University and directs the Center for Advanced Biotechnology and Medicine.

A physician and microbiologist, he has led pioneering research on the human microbiome's role in health and diseases like asthma, obesity, diabetes, and cancer.

Dr. Blaser has served as President of the Infectious Diseases Society of America, Chair of the Board of Scientific Counselors of the National Cancer Institute, and Chair of the Advisory Board for Clinical Research of the NIH.

He has authored over 600 scientific articles, holds 24 U.S. patents, and wrote "Missing Microbes."

Dr. McQuade is a melanoma medical oncologist and physician-scientist whose translational research focuses on the interaction between host-level factors, tumor biology, immunity and outcomes.

Previously at MD Anderson, she has published in over 40 peer-reviewed journals and presented at conferences across the nation.

Her research has been featured in The New York Times and The Houston Chronicle, including her widely cited paper in The Lancet Oncology on the association between body-mass index and outcomes in patients with metastatic melanoma.

Dr. Per Falk has advanced microbiome science for over 30 years. As President and Chief Scientific Officer of Ferring Pharmaceuticals, he oversaw the development of the first FDA-approved microbiome therapy.

Previously, he held senior roles at Novo Nordisk and AstraZeneca. Dr. Falk has also served as an Associate Professor at the Karolinska Institute and Washington University School of Medicine.

Jo is a social change practitioner, philanthropy educator, advisor and coach with 25 years working with global organisations to achieve change.

She founded Pi in 2019 to deliver private, confidential and pitch-free philanthropy education to families globally. Former CEO of AMREF UK and Alfanar, and Global Director of The Philanthropy Workshop, Jo has been named a top 10 philanthropy advisor by Spear's since 2014.

She holds degrees from Oxford and London Universities.

Stephen is the Managing Director of Baccata Trustees Limited, a Jersey regulated provider of fiduciary services.

He is a Fellow of the Institute of Chartered Accountants in England and Wales and a Fellow of the Chartered Association of Certified Accountants with over thirty years of broad experience advising private clients from around the globe.

Stephen has held a number of senior positions with Jersey based trust companies. He also undertakes a number of roles for locally based charities

Christopher has 30 years of experience in the financial services sector in a variety of executive rand board roles across capital markets, investment banking and venture investments.

Previous positions include Group CFO at Nordea Bank, Co-head of Debt Capital Markets at Barclays Bank, and Executive Director at Morgan Stanley.  Christopher currently serves on the board of 2 public listed financial services firms and chairs their investment and risk and audit committees.

He holds a Master of Science in Accounting and Finance and a Bachelor of Science in Economics from the London School of Economics.

David spent 6 months short of 50 years in the oil industry. In 1992 David co-founded Greenergy which is now the UK’s largest downstream oil company by some distance.

The company was sold in May 2017 and the resulting proceeds were bequeathed to Seerave to fund its research and philanthropic activities.

Elisabeth has more than twenty years of experience working within Fine Arts and Museums in Sweden as a Project Manager, Programmer, Curator, and Museum Director.

Prior to her Fine Arts studies, she trained as a nurse. In 2016 she joined her father to build up the Seerave Foundation with the conviction to change the standard of care for cancer patients.